Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BCG vs. Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer: A Randomized Prospective Study

NCT00696579 is registered in ClinicalTrials.gov with University Of Perugia as lead sponsor.

NCT NCT00696579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BCG vs. Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer: A Randomized Prospective Study
Lead sponsor
University Of Perugia
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2004
Completion date
Not reported
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer